Analytical Data
-
基因名
HRASLS3
- Application
-
别名
PLAAT3;HRASLS3;HREV107;PLA2G16;Phospholipase A and acyltransferase 3
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P53816
-
表达区间
12-132aa
-
氨基酸序列
DLIEIFRPFYRHWAIYVGDGYVVHLAPPSEVAGAGAASVMSALTDKAIVK KELLYDVAGSDKYQVNNKHDDKYSPLPCSKIIQRAEELVGQEVLYKLTSE NCEHFVNELRYGVARSDQVRD
-
分子量
14 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HRASLS3, or HRAS-like suppressor 3, is a member of the RAS (Rat Sarcoma) superfamily of proteins, which play critical roles in various cellular processes, including cell proliferation, differentiation, and survival. Research into HRASLS3 has gained attention due to its potential implications in cancer biology, cellular signaling pathways, and metabolic regulation. Unlike other RAS family members, HRASLS3 has been suggested to possess unique regulatory functions, such as influencing lipid metabolism and acting as a tumor suppressor in certain contexts. Initial studies have indicated that HRASLS3 may interact with key signaling proteins, thereby modulating pathways involved in tumor progression and metastasis. Furthermore, the characterization of HRASLS3’s structure and function could provide insights into its role in disease mechanisms and offer potential therapeutic targets for cancer treatments. The ongoing exploration of HRASLS3 and its biological significance underscores the need for comprehensive studies to elucidate its mechanisms of action, interactions, and potential as a biomarker for innovative cancer therapies.
